ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01334047
Recruitment Status : Terminated (The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol with an expected more efficient vaccine is currently being written.)
First Posted : April 12, 2011
Last Update Posted : August 25, 2014
Sponsor:
Information provided by:
Oslo University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2013
  Estimated Study Completion Date : April 2022